智通财经APP获悉，香港中医理疗公司美妍堂(MCTA.US)于周二登陆美股纳斯达克，首次公开募股(IPO)定价为每股4美元，位于此前公布的4-6美元定价区间的低端。该公司在其IPO中发行了160万股股票，筹集了600万美元。该股上市首日收盘飙涨75.0%，报7.0美元。
据悉，美妍堂总部位于香港，提供中医药(TCM)为灵感的疗法和产品。该公司目前在香港拥有4家以“美妍堂(Beauty Lab)”为品牌的健康中心，提供美容、健康和产后服务及产品。该公司还为男性提供量身定制的中医疗法。数据显示，截至2024年9月30日的六个月，美妍堂营收为296万美元，上年同期为261万美元，相应的净利润分别为47万美元、38万美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.